No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 2,424 | 2,999 | 3,590 | 3,008 | 2,953 | 2,631 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 248 | 174 | 401 | 33 | -104 | -59 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Nantong Acetic Acid Chemical Co., Ltd., founded in 1959 and operating from its headquarters in Nantong, China, is a significant entity involved in the production and global distribution of a diverse range of chemical compounds. The company's extensive product catalog features a wide array of food and animal feed additives, including sorbic acid, potassium sorbate, dehydroacetic acid, sodium dehydroacetate, nicotinic acid, nicotinamide, and clopidol. It also manufactures and supplies critical intermediates essential for pharmaceutical and pesticide production, such as methyl acetoacetate, ethyl acetoacetate, 2-cyanopyridine, 3-cyanopyridine, and 4-cyanopyridine. For the coloration sector, the firm provides a comprehensive selection of dye and pigment intermediates, notably acetoacetanilide, 2-methylacetoacetanilide, N-acetoacetyl-4-methylaniline, o-acetoacetaniside, p-acetoacetaniside, p-acetophenetidide, 2,4-dimethylacetoacetanilide, acetoacetic-2,5-dimethoxyanilide, 1-(p-tolyl)-3-methyl-5-pyrazolone, 1-phenyl-3-methyl-5-pyrazolone, 5-acetoacetlamino benzimdazolone, naphthol AS-G, 4-chloro-2,5-dimethoxyacetoacetanilide, and N,N'-(1,4-phenylene)bis(acetoacetamide). Furthermore, its offerings encompass fundamental organic chemical raw materials like diketene, acetonitrile, and crotonaldehyde. Beyond its standard lines, Nantong Acetic Acid Chemical also caters to specific client requirements through custom synthesis services, delivering bespoke products such as sodium acetate anhydrous, N-methylacetoacetamide, 2-isopropyl-4-methyl-6-pyrimidinone, 3-methyl-1-(4-sulfophenyl)-5-pyrazolone, 1-(3-sulfophenyl)-3-methyl-5-pyrazolone, 1-(3'-chlorophenyl)-3-methyl-5-pyrazolone, and 1-(2-chlorophenyl)-3-methyl-5-pyrazolone.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Nantong Acetic Acid Chemical Co., Ltd. (603968.SS)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Nantong Acetic Acid Chemical Co., Ltd., founded in 1959 and operating from its headquarters in Nantong, China, is a significant entity involved in the production and global distribution of a diverse range of chemical compounds. The company's extensive product catalog features a wide array of food and animal feed additives, including sorbic acid, potassium sorbate, dehydroacetic acid, sodium dehydroacetate, nicotinic acid, nicotinamide, and clopidol. It also manufactures and supplies critical intermediates essential for pharmaceutical and pesticide production, such as methyl acetoacetate, ethyl acetoacetate, 2-cyanopyridine, 3-cyanopyridine, and 4-cyanopyridine. For the coloration sector, the firm provides a comprehensive selection of dye and pigment intermediates, notably acetoacetanilide, 2-methylacetoacetanilide, N-acetoacetyl-4-methylaniline, o-acetoacetaniside, p-acetoacetaniside, p-acetophenetidide, 2,4-dimethylacetoacetanilide, acetoacetic-2,5-dimethoxyanilide, 1-(p-tolyl)-3-methyl-5-pyrazolone, 1-phenyl-3-methyl-5-pyrazolone, 5-acetoacetlamino benzimdazolone, naphthol AS-G, 4-chloro-2,5-dimethoxyacetoacetanilide, and N,N'-(1,4-phenylene)bis(acetoacetamide). Furthermore, its offerings encompass fundamental organic chemical raw materials like diketene, acetonitrile, and crotonaldehyde. Beyond its standard lines, Nantong Acetic Acid Chemical also caters to specific client requirements through custom synthesis services, delivering bespoke products such as sodium acetate anhydrous, N-methylacetoacetamide, 2-isopropyl-4-methyl-6-pyrimidinone, 3-methyl-1-(4-sulfophenyl)-5-pyrazolone, 1-(3-sulfophenyl)-3-methyl-5-pyrazolone, 1-(3'-chlorophenyl)-3-methyl-5-pyrazolone, and 1-(2-chlorophenyl)-3-methyl-5-pyrazolone.